Zhenqian Wu
600 Yishan Road
Shanghai, 200233, China
Shanghai, 200233, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
CD133+-Derived Exosomes Carrying EIF3B Mediate Cell Metasta sis and Stemness in Colorectal Cancer.
Journal: Current cancer drug targets
Published: September 24, 2024
Nomogram for predicting the probability of permanent stoma in patients with acute obstructive colorectal cancer.
Journal: Langenbeck's archives of surgery
Published: January 13, 2023
Dioscin Inhibited Glycolysis and Induced Cell Apoptosis in Colorectal Cancer via Promoting c-myc Ubiquitination and Subsequent Hexokinase-2 Suppression.
Journal: OncoTargets and therapy
Published: July 22, 2019
Construction of a circular RNA-microRNA-messengerRNA regulatory network in stomach adenocarcinoma.
Journal: Journal of cellular biochemistry
Published: December 04, 2018
Solute carrier family 34 member 2 overexpression contributes to tumor growth and poor patient survival in colorectal cancer.
Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: September 19, 2017
The BET-Bromodomain Inhibitor JQ1 synergized ABT-263 against colorectal cancer cells through suppressing c-Myc-induced miR-1271-5p expression.
Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: May 15, 2017
The chemokine CXCL9 expression is associated with better prognosis for colorectal carcinoma patients.
Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: August 30, 2015
The prognostic significance of chemokine receptor CXCR3 expression in colorectal carcinoma.
Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: December 02, 2011
Showing 1-8 of 8
Last Updated: 09/26/2026